Food and Drug Administration’s Regulatory Shift on Direct-To-Consumer Genetic Tests for Cancer Risk

Cancer - United States
doi 10.1002/cncr.31773
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Food and Drug Administration’s Revolving Door

C&EN Global Enterprise
2019English

Direct-To-Consumer Genetic Testing

British Medical Journal
Medicine
2019English

Direct-To-Consumer Genetic Testing

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2009English

Effect of Direct-To-Consumer Genetic Tests on Health Behaviour and Anxiety: A Survey of Consumers and Potential Consumers

Journal of Genetic Counseling
Genetics
2013English

Autobiologies on YouTube: Narratives of Direct-To-Consumer Genetic Testing

New Genetics and Society
GeneticsHealth PolicyLegal AspectsHealthEthicsIssues
2014English

Genetic Testing Integration Panels (GTIPs): A Novel Approach for Considering Integration of Direct-To-Consumer and Other New Genetic Tests Into Patient Care

Journal of Genetic Counseling
Genetics
2012English

Policy and Regulatory Implications of the New Frontier of Forensic Genomics: Direct-To-Consumer Genetic Data and Genealogy Records

Current Issues in Criminal Justice
2019English

An Evaluation of US Food and Drug Administration’s Program to Register HIV Drugs for Use in Resource-Constrained Settings

JAMA network open
Medicine
2019English

Impact of Direct-To-Consumer Genetic Testing on Australian Clinical Genetics Services

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy